HomeAdalimumab BwwdAdalimumab Bwwd + Theophylline

Does Adalimumab Bwwd Interact with Theophylline?

Adalimumab Bwwd and Theophylline have a moderate drug interaction according to U.S. FDA drug labeling data. HADLIMA may influence CYP450 enzyme formation; monitoring of theophylline concentration recommended with dose adjustment as needed. The mechanism involves adalimumab may suppress cyp450 enzyme formation by antagonizing cytokine activity. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Adalimumab Bwwd Class
Tumor Necrosis Factor Blocker
Theophylline Class
Methylxanthine
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Adalimumab Bwwd and Theophylline occurs because adalimumab may suppress cyp450 enzyme formation by antagonizing cytokine activity. Clinically, this means hadlima may influence cyp450 enzyme formation; monitoring of theophylline concentration recommended with dose adjustment as needed. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Adalimumab Bwwd and your doctor is considering prescribing Theophylline (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Adalimumab Bwwd(Adalimumab-Bwwd)+💊 Theophylline(Theophylline)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Tumor Necrosis Factor Blocker
Drug B class
Methylxanthine
Source
NLP:adalimumab-bwwd

What this means in plain English

HADLIMA may influence CYP450 enzyme formation; monitoring of theophylline concentration recommended with dose adjustment as needed.

What the FDA label says

"Adalimumab may suppress CYP450 enzyme formation by antagonizing cytokine activity"

📖 Source: NLP:adalimumab-bwwd

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Adalimumab Bwwd and Theophylline against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.